2-Bromo-1-(THP-yl)-1H-imidazole: Synthesis & Handling Protocol
2-Bromo-1-(THP-yl)-1H-imidazole: Synthesis & Handling Protocol
2-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-imidazole is a versatile, N1-THP-protected 2-bromoimidazole building block widely employed in medicinal and heterocyclic chemistry for halogen-metal exchange, cross-coupling reactions, and the construction of complex nitrogen-containing scaffolds.
- Chemical Name
- 2-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-imidazole
- SKU
- B732538
- Core Functionality
- N1-THP-protected 2-bromoimidazole; C–Br bond available for lithiation or cross-coupling
- Protecting Group
- Tetrahydropyran-2-yl (THP) at N1; removable under mild acidic aqueous conditions
- Primary Applications
- Halogen-metal exchange, Pd-catalyzed cross-coupling (Suzuki, Negishi), nucleophilic substitution
- Storage Recommendation
- Store under inert atmosphere (N₂ or Ar) at 2–8 °C, away from moisture and light
Compound Overview and Physical Properties
2-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-imidazole (Aladdin SKU B732538) is an N1-protected 2-bromoimidazole in which the tetrahydropyran-2-yl (THP) group serves as a standard acid-labile protecting group on the imidazole nitrogen. The molecule combines the electrophilic character of a C2-bromine substituent with the stability conferred by THP protection, making it a reliable intermediate for multi-step heterocyclic synthesis.
The THP group is introduced via reaction of imidazole with 3,4-dihydro-2H-pyran (DHP) under acidic catalysis, and the resulting N-THP imidazole is then brominated at C2. The C2–Br bond is activated toward both directed metalation (e.g., n-BuLi at low temperature) and palladium-catalyzed cross-coupling. Typical physical characteristics of N-THP-protected bromoimidazoles include a pale-yellow to off-white solid or oil appearance; refer to the product certificate of analysis (CoA) for the confirmed melting point, purity, and spectral data specific to lot B732538.
Materials and Safety Considerations
Required materials: 2-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-imidazole (B732538), anhydrous solvents (THF, diethyl ether, or DMF depending on application), inert gas supply (N₂ or Ar), standard glassware for Schlenk or glovebox technique, and appropriate nucleophiles or coupling partners as required by the downstream reaction.
Safety: Organobromine heterocycles should be handled with standard laboratory precautions. Wear appropriate personal protective equipment (PPE) including nitrile gloves, laboratory coat, and safety glasses. Work in a well-ventilated fume hood. Consult the Safety Data Sheet (SDS) for B732538 before use; specific GHS hazard classifications, first-aid measures, and disposal instructions are detailed therein. Because the compound is moisture-sensitive, minimize exposure to ambient air during weighing and transfers.
Waste disposal: Dispose of halogenated organic waste in accordance with local institutional and regulatory requirements for halogenated solvents and reagents.
Step-by-Step Protocol for Halogen–Metal Exchange and Functionalization
The following general procedure outlines the use of B732538 as a precursor for directed lithiation followed by electrophile quench. Adapt stoichiometry and conditions to the specific target molecule.
- Inert atmosphere setup: Flame-dry all glassware and purge with N₂ or Ar. Transfer all moisture-sensitive reagents via syringe or cannula.
- Dissolution: Dissolve 2-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-imidazole (1.0 equiv, B732538) in anhydrous THF (typically 0.1–0.5 M) under inert gas at −78 °C.
- Metalation: Add n-butyllithium (1.05–1.1 equiv, 2.5 M in hexanes) dropwise via syringe at −78 °C. Stir for 30–60 minutes to ensure complete halogen–lithium exchange at C2.
- Electrophile addition: Add the desired electrophile (e.g., aldehyde, ketone, DMF, or iodine) dropwise at −78 °C. Allow the reaction to warm gradually to the temperature required for complete conversion (typically −78 °C to 0 °C or room temperature, depending on electrophile reactivity).
- Workup: Quench with saturated aqueous NH₄Cl. Extract with ethyl acetate (3×), dry the combined organic layers over Na₂SO₄ or MgSO₄, filter, and concentrate under reduced pressure.
- THP deprotection (if required): Treat the crude product with dilute aqueous HCl (e.g., 1 N, 5 equiv) in THF/water (1:1) at room temperature for 1–4 hours. Monitor by TLC or LC-MS. Neutralize, extract, and purify.
- Purification: Purify by silica gel column chromatography using an appropriate solvent gradient. Confirm identity and purity by ¹H NMR, ¹³C NMR, and HRMS.
Note: Reaction times and temperatures are general guidelines. Optimize for each specific substrate and electrophile. All specific yields and conditions should be validated in-house.
Storage, Stability, and Quality Control
Storage: Store B732538 under an inert atmosphere (N₂ or Ar) at 2–8 °C. Keep the container tightly sealed and protected from moisture and light. Improper storage may lead to hydrolysis of the THP protecting group or decomposition of the C–Br bond.
Stability: The THP group is stable under neutral and basic conditions but is cleaved under mild acidic aqueous conditions, which is exploited for deprotection. The C2–Br bond is stable to storage conditions but reactive toward strong nucleophiles, organolithium reagents, and transition-metal catalysts under appropriate reaction conditions.
Quality control: Aladdin Scientific provides a Certificate of Analysis (CoA) for each lot of B732538 confirming identity (NMR, MS), purity (HPLC or GC), and appearance. Request the CoA at time of ordering or download it from the product page. If analytical data are required prior to use (e.g., for GMP-adjacent workflows), contact Aladdin technical support.
Frequently asked questions
What is the purpose of the THP protecting group in this compound?
The tetrahydropyran-2-yl (THP) group protects the N1 position of the imidazole ring, preventing undesired N-alkylation or N-metalation during synthetic transformations. It is selectively removed under mild acidic aqueous conditions (e.g., dilute HCl or p-TsOH in aqueous THF) to reveal the free NH imidazole after the key bond-forming step is complete.
Can 2-Bromo-1-(tetrahydro-2H-pyran-2-yl)-1H-imidazole be used directly in palladium-catalyzed cross-coupling reactions?
Yes. The C2–Br bond of this compound is suitable for palladium-catalyzed cross-coupling reactions such as Suzuki–Miyaura (with arylboronic acids) and Negishi coupling (with organozinc reagents). The THP group remains intact under standard Pd-catalyzed coupling conditions, allowing sequential functionalization followed by deprotection. Optimal ligand, base, and solvent selection should be determined empirically for each coupling partner.
How should I handle this compound if the THP group is accidentally hydrolyzed?
If THP deprotection occurs inadvertently, the product will be 2-bromo-1H-imidazole, which retains the C2–Br bond and can still be used in downstream reactions, though N-selectivity in subsequent steps may be reduced. To prevent accidental hydrolysis, always handle B732538 in anhydrous conditions and avoid exposure to acidic media. If degradation is suspected, confirm compound identity by NMR or LC-MS before use.
What solvents are recommended for dissolving B732538?
Anhydrous THF, diethyl ether, and DMF are commonly used solvents for N-THP-protected bromoimidazoles. The choice depends on the downstream reaction: THF and diethyl ether are preferred for organolithium chemistry, while DMF or DMA may be used for cross-coupling. Avoid protic solvents (water, alcohols) as they may promote THP hydrolysis.
References
- Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 4th ed.; Wiley: Hoboken, NJ, 2007. (General reference for THP protecting group chemistry.)
- Clayden, J. Organolithiums: Selectivity for Synthesis; Elsevier: Oxford, 2002. (Reference for halogen–metal exchange and directed lithiation methodology.)
- Schnürch, M.; Flasik, R.; Khan, A. F.; Spina, M.; Mihovilovic, M. D.; Stanetty, P. Cross coupling reactions on azole ring systems. Eur. J. Org. Chem. 2006, 3283–3307. (Review of cross-coupling on imidazole and related heterocycles.) doi:10.1002/ejoc.200600093
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)